DMARD Medication Review >3 months (HP037)
DMARD Medication Review >3 months (HP037)
Overview/Purpose
This protocol ensures that users are warned if they set a medication review to over 3 months if the patient is on DMARD medication
What does it do?
- When a medication review is coded, checks to make sure that this is not more than 3 months in the future.
Why is it important?
There are well established guidelines for monitoring of Disease Modifying Anti Rheumatic Drugs (DMARDS) and none of these allow more than 3 months to pass before the patient needs to be reviewed again. This protocol acts as a safety net to ensure that users do not advance the planned medication review date by more than 3 months in the future.
What does it look like?
See below screenshot which shows an example of the protocol in use:
System Dependencies
Relies on using the clinical system to record medication issues as well as medication reviews.
System Triggers
System trigger: Add a code
Code: All medication review codes
Run mode: Always run
Enable trigger for: All staff
Change management considerations
Your team need to understand the requirements for DMARD monitoring.
How to get it
This protocol is automatically installed in your system. If you are waiting for installation and want us to prioritise your site, please submit a ticket to request this.
Related Articles
Adding hospital medication
EMIS provides the ability to record medication which is prescribed by third parties such as hospitals. This is a useful clinical safety feature to guide primary care clinicians in being aware of all medication a patient is taking. Typically such ...SABA Overuse Alert (6+ in 6 Months)
? SABA Overuse Alert (6+ in 6 Months) This shared component flags when a patient has been issued six or more Short-Acting Beta-Agonist (SABA) inhalers (e.g. salbutamol) in the past 6 months. It serves as a key marker of poor asthma control and risk ...Inhaler Review Alert – Dormant or Resolved Coding
? Inhaler Review Alert – Dormant or Resolved Coding This shared component appears when a patient with an asthma diagnosis has not been issued an inhaler in the past 12 months. It prompts clinicians to reassess whether the diagnosis is still active ...Asthma Review Follow-Up
? Asthma Review Follow-Up This shared component helps clinicians complete and close off a structured asthma review, ensuring all QOF elements are captured and future care is planned appropriately. ? When Will I See This? At the end of a full asthma ...TSH Results Review (HP173)
HP173 TSH Results Review Type: Protocol Overview/Purpose The HP173 TSH Results Review protocol is designed to streamline the review process for new Thyroid Stimulating Hormone (TSH) results for patients diagnosed with hypothyroidism or ...